Skip to main content

Table 1 Association PAK4 expression with clinicopathological features of human cervical cancer

From: PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway

Characteristics No. (n = 95) High PAK4 Low PAK4 P value
N % N %  
Age (years) 93      0.42131
 <65 56 24 55.81 32 64.00  
 ≥65 37 19 44.19 18 36.00  
Tumor size (cm)       0.59763
 <4 46 20 46.51 26 52.00  
 ≥4 47 23 53.49 24 48.00  
HPV       0.99205
 Positive 67 31 72.09 36 72.00  
 Negative 26 12 27.91 14 28.00  
Tumor histology       0.25219
 Squamous 68 29 67.44 39 78.00  
 Adenocarcinoma 25 14 32.56 11 22.00  
FIGO stage       0.02888*
 Ib 24 6 13.95 18 36.00  
 IIa 20 8 18.60 12 24.00  
 IIb 25 13 30.23 12 24.00  
 IIIa 24 16 37.21 8 16.00  
LN metastasis       0.00525
 Positive 38 24 55.81 14 27.45  
 Negative 56 19 44.19 37 72.55  
Distant metastasis       0.02105
 Positive 26 17 39.53 9 18.00  
 Negative 67 26 60.47 41 82.00  
Histological grade       0.03464
 Poor 41 24 55.81 17 34.00  
 Well/moderade 52 19 44.19 33 66.00  
  1. *: with significance